Cart
sales@molnova.com
Piprozolin
CAS No. 17243-64-0
Piprozolin( —— )
Catalog No. M34681 CAS No. 17243-64-0
Piprozolin (W 3699) is a new type of choleretic acid that shows slight analgesic properties at high doses during chronic experiments.Piprozolin has a slight induction of certain enzymes of the oxidative system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 143 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 343 | In Stock |
|
| 50MG | 486 | In Stock |
|
| 100MG | 684 | In Stock |
|
| 200MG | 923 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePiprozolin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiprozolin (W 3699) is a new type of choleretic acid that shows slight analgesic properties at high doses during chronic experiments.Piprozolin has a slight induction of certain enzymes of the oxidative system.
-
DescriptionPiprozolin (W 3699) is a new type of choleretic acid that shows slight analgesic properties at high doses during chronic experiments.Piprozolin has a slight induction of certain enzymes of the oxidative system.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17243-64-0
-
Formula Weight298.4
-
Molecular FormulaC14H22N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(SC(=CC(OCC)=O)N1CC)N2CCCCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ac-Phe-NH2
Ac-Phe-NH2 is a non-competitive inhibitor of polyubiquitin chain elongation at Ki value of 8 ± 1.2 mM.
-
H-DL-Gly-OBzl HCl
Compound Fr13877 is a useful organic compound for research related to life sciences.
-
Burosumab
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
